Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis
Table 1
Methodological and design criteria of all 12 included articles [9].
Author, year of publication
Type of studya
Study designb
Patient selectionc
Inclusion/exclusion criteriad
Spectrum of patientse
Description contrast administrationf
Time interval 2–4 days (48–96 h)g
Complete verificationh
Abdurrezzak (2014)
Cohort
Single centre
Yes
Yes
No
Yes
Yes
Yes
Alparslan Kurtul (2017)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Derya (2015)
Cohort
Single centre
Unclear
Yes
Yes
Yes
Yes
Yes
Giancarlo (2010)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Giancarlo Marenzi (2004)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Muhammet (2016)
Cohort
Single centre
Yes
Yes
No
Yes
Yes
Yes
Nyman U (2008)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Saim (2016)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Samuel (2015)
Cohort
Multicenter
Yes
Yes
Yes
Yes
Yes
Yes
Stylianos (2013)
Cohort
Multicenter
Yes
Yes
Yes
No
Yes
Yes
Yong Liu (2011)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
Yuan-Hui Liu (2017)
Cohort
Single centre
Yes
Yes
Yes
Yes
Yes
Yes
aThe study was a cohort or randomized controlled trial (RCT). bThe study was a single centre or multicentre study. cA consecutive or random sample of patients was enrolled. dInclusion/exclusion criteria were specified. eThe spectrum of patients was representative of the patients who will receive the test in daily practice. fThe administration of the contrast medium was described with sufficient details. gThe time period between contrast medium administration and follow-up was reasonable (performed within 2–4 days). hThe whole (or random) sample underwent follow-up for occurrence/determination of CIN.
